ALK resistance mutations and efficacy of lorlatinib in advanced anaplastic lymphoma kinase-positive non–small-cell lung cancer
Journal
Journal of Clinical Oncology
Journal Volume
37
Journal Issue
16
Pages
1370-1379
Date Issued
2019
Author(s)
Shaw A.T.
Solomon B.J.
Besse B.
Bauer T.M.
Soo R.A.
Riely G.J.
Ignatius Ou S.-H.
Clancy J.S.
Li S.
Abbattista A.
Thurm H.
Satouchi M.
Camidge D.R.
Kao S.
Chiari R.
Gadgeel S.M.
Felip E.
Martini J.-F.
SDGs
Publisher
American Society of Clinical Oncology
Type
journal article